The First Affiliated Hospital of Xiamen University
🇨🇳China
Clinical Trials
95
Active:3
Completed:18
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:12
Phase 2:32
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (77 trials with phase data)• Click on a phase to view related trials
Phase 2
32 (41.6%)Not Applicable
27 (35.1%)Phase 1
12 (15.6%)Phase 4
3 (3.9%)Phase 3
2 (2.6%)Early Phase 1
1 (1.3%)Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow Ratio
Completed
- Conditions
- Coronary Arterial Disease (CAD)
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Target Recruit Count
- 200
- Registration Number
- NCT07110298
- Locations
- 🇨🇳
the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
Not Applicable
Recruiting
- Conditions
- Locally Advanced Nasopharyngeal CarcinomaImmunotherapyInduction Therapy
- Interventions
- Drug: Iparomlimab/Tuvorlimab(QL-1706) and modified TPF regimen
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Target Recruit Count
- 30
- Registration Number
- NCT07085234
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
68Ga-MY6349 PET/CT in Solid Tumors
Recruiting
- Conditions
- PET/CTTrop2Solid Tumor
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-15
- Target Recruit Count
- 300
- Registration Number
- NCT07046702
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
🇨🇳The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
PET/CT for Trop2 ADC Response Evaluation Cancers
Recruiting
- Conditions
- Breast CancerTrop2PET/CT
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-15
- Target Recruit Count
- 50
- Registration Number
- NCT07046689
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
T-cell Developmental Status in Patients With Malignant Hematological Tumors
Recruiting
- Conditions
- Hematologic Malignancy
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-07-23
- Target Recruit Count
- 75
- Registration Number
- NCT07035938
- Locations
- 🇨🇳
Zhijuan Lin, Xiamen, Fujian, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
No news found